QCI Interpret One
Oncology variant interpretation just got more precise
Deliver oncologist-ready variant interpretation reports
Today’s clinical labs are under mounting pressure to interpret next-generation sequencing (NGS) tests faster and with greater precision than ever before. That’s why we created QCI Interpret One.
With QCI Interpret One, lab directors can prepare, prioritize and report on clinically relevant variants associated with solid tumors and hematological malignancies without the time-consuming step of researching and writing variant- and disease-specific evidence summaries. Users get access to an “expert second opinion” for variant classification, and they can deliver professional reports directly to physicians and oncologists to better inform clinical decision making.
QCI Interpret One
- Flexible and automatable QIAGEN Clinical Insights (QCI) software with the trusted services of N-of-One, a QIAGEN company and leading provider of somatic variant interpretation
Applications
- Solid tumors
- Hematological malignancies
0
+
decision-ready oncologist-reviewed variant interpretative comments
Advance your complex genomic profiling services to enable personalized cancer care
Confidently interpret NGS variants
Immediately access over 170,000 decision-ready oncologist-reviewed variant interpretative comments, plus expertly curated professional guidelines, FDA therapies, clinical trials, and published literature, for confident decision-making.
Accelerate test turnaround time
Speed up variant interpretation with dynamically computed disease-specific variant classifications, immediate access to interpretive comments, and automatable workflows to help you scale for higher test volumes.
Deliver oncologist-ready reports
Generate customizable and standardized clinical reports with variant- and disease-specific information, including molecular function, and diagnostic, prognostic, and therapeutic relevance, available treatments, and open clinical trials.
Download the QCI Interpret One brochure here.
“QIAGEN’s new QCI Interpret One is impressive. It combines the former N-of-One interpretation summaries with QIAGEN’s QCI Interpret structured variant interpretation database. No one is better than QIAGEN for Variant Interpretation. From a large complex panel you can quickly filter variants, classify variants according to AMP and NCCN guidelines and add disease specific and oncologist reviewed pre-formulated interpretive comments. The depth, breadth and quality quickly give you the confidence you need when there is so much information and complexity to deal with now."
Ravindra Kolhe, MD, PhD
Chief, Section of Molecular and Genetic Pathology
Augusta University
Confident classifications for every variant, every disease, every patient
The content core of QCI Interpret One, the QIAGEN Clinical Knowledge Base transforms unstructured data into actionable insight. By aggregating, manually curating, and modeling scientific literature and professional guidelines with semantic consistency, the QIAGEN Clinical Knowledge Base captures biological, phenotypic, therapeutic, and outcomes information that enables QCI Interpret One to compute variant- and disease-specific classifications for every alteration in every disease for every patient case.
Accelerate test turnaround time
QCI Interpret One enables clinical labs to speed up variant interpretation through automatable workflows and integrated curation and interpretation services.
QCI Interpret One gives you:
Decision-ready interpretations at your fingertips
Configurable and automatable workflows
On-demand clinical curation and interpretation services
VCF to oncologist-ready report
Instantly prioritize clinically relevant variants
Dynamically compute disease-specific variant classifications and drug and trial selection
Generate customizable and standardized clinical reports
Access to variant- and disease-specific content
-
-
-
-
-
-
- Biological, prognostic, diagnostic, and therapeutic evidence
- Approved treatments and open/recruiting clinical trials
- Expert molecular function summaries
-
-
-
-
-
Expert decision-ready interpretations with oncologist-reviewed clinical evidence
Need secondary NGS analysis? QIAGEN Clinical Analysis and Interpretation Services can help. Learn more here.
Actionable clinical NGS reports
The content, transparency, and delivery of clinical oncology NGS test reports are critical for timely and effective patient care. QCI Interpret One supports customizable and standardized reporting to ensure adherence with industry guidelines, while also making reports easy to understand and act upon by oncologists and clinicians.
QCI Interpret One is designed to augment in-house expertise. By providing you with all of the content necessary to generate a comprehensive, patient-specific report, yet giving you full control over final classifications, comments, and recommendations, the software and service enhance decision-making in the clinical workflow.
QCI Interpret One reports include:
- Oncologist-reviewed variant- and disease-specific interpretation summaries offering concise, intermediate, or comprehensive information on:
- Molecular function
- Therapeutic, prognostic, and diagnostic relevance
- Variant interactions, such as effect of co-occurring variants on therapies, drug resistance and sensitivities
- Clinical practice guideline recommendations
- Relevant local recruiting clinical trials
- FDA-approved drug therapies
- Primary literature references
Application Note
Developing a robust, automated, and streamlined clinical NGS workflow for hematological malignancies
In this application note, we discuss the importance of streamlined clinical NGS workflows within the hematologic-oncology space. Learn how to develop a robust, automated, and streamlined NGS analysis pipeline for the interpretation and reporting of genomic alterations associated with hematological malignancies.
On-demand webinar
An in-depth look at QCI Interpret One with our clinical NGS testing experts
In this on-demand webinar, you will:
- The QCI Interpret One software works, including an overview of data upload, workflow configuration, and variant filtering, prioritization, and classification
- The service component of QCI Interpret One is accessed, with information on scope and turnaround time
- QCI Interpret One can be fully customized to support any NGS panel for cancer, regardless of size, content or manufacturer
QCI Interpret One Sample Report
Download an annotated sample report for QCI Interpret One
Are you an existing QCI Interpret user?
Speak with a QCI expert about upgrading to QCI Interpret One
Request a free
personalized
consultation
The best way to discover the benefits of QCI Interpret One is to request a free, no-obligation consultation tailored to your lab’s needs.
Related clinical testing solutions
QCI Interpret
Clinical decision support software enabling faster test turnaround times and higher confidence reporting for any indication on your sequencing platform
QCI Precision Insights
Reimagine your clinical genomic interpretation with same day, expert variant classification services tailored to your oncology panel
Clinical Analysis and Interpretation Services
Leverage the benefits of automation and expert support to improve test turnaround times and clinical reporting capabilities